Investigational Site Number 840143 — Chaska, Minnesota

Investigational Site Number 840143 is a clinical research site located in Chaska, Minnesota, United States 55318.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840143 has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chaska

Browse all research sites in Minnesota · View every site in Chaska

• Minnesota Oncology Hematology PA-Chaska
• GSK Investigational Site
• Pfizer Investigational Site
• Ridgeview Research
• Ridgeview Research Two Twelve Medical Center
• Furiex Research Site
• Ridgeview Specialty Clinic Chaska - Neurology /ID# 204384
• Minnesota Oncology Hematology, P.A.
• Nicox Clinical Site
• Investigative Site
• Minnesota Landscape Arboretum
• Pain Centers of Minnesota

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840143?

Investigational Site Number 840143 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840143 conducted?

Investigational Site Number 840143 has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Investigational Site Number 840143 accredited by Crixeo Clinical Trials?

Investigational Site Number 840143 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840143?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.